-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

Benzinga·09/25/2026 12:57:41
Listen to the news
Guggenheim analyst Vamil Divan initiates coverage on Entera Bio (NASDAQ:ENTX) with a Buy rating and announces Price Target of $11.